tirzepatide phase 2 obesity once weekly for the treatment of in people with type diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, 3 trial Tirzepatide Demonstrates 22.5% Weight Loss
Pay in 4 interest-free payments of $5.45 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
























